Tice Bcg Powder, For Suspension
Product Images NDC 0052-0602

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Tice Bcg (NDC 0052-0602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mL Vial Carton)

Principal Display Panel (50 mL Vial Carton)
Packaging label for TICE BCG single-dose vial, a BCG live powder for suspension used intravesically. The label features a purple vial illustration with the text "BCG LIVE (for Intravesical Use) TICE BCG Rx only". Storage instructions recommend refrigeration at 2-8°C and protection from direct sunlight. The label includes usage details, barcode, manufacturer Merck Sharp & Dohme Corp., and U.S. license information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.